Seattle Genetics

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2015	Cogent Biosciences	$65.0M Series B	Liam Ratcliffe	Access Biotechnology, Atlas Venture, Brandon Capital Partners, Josh Resnick, Brace Pharma Capital, Cowen Private Investments, F-Prime Capital, Jennison Associates, Novo Holdings, Sabby Management, Sanofi Ventures, Sectoral Asset Management, Wellington Management

Total Raised

N/A

Valuation

N/A